Cargando…
Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
INTRODUCTION: Hepatocellular carcinoma (HCC) is an aggressive malignancy with steadily increasing incidence rates worldwide and poor therapeutic outcomes. Studies show that metabolic reprogramming plays a key role in tumor genesis and progression. In this study, we analyzed the metabolic heterogenei...
Autores principales: | He, Zehua, Chen, Qingfeng, He, Wanrong, Cao, Junyue, Yao, Shunhan, Huang, Qingqiang, Zheng, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017446/ https://www.ncbi.nlm.nih.gov/pubmed/36937389 http://dx.doi.org/10.3389/fonc.2023.1086604 |
Ejemplares similares
-
Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023) -
Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma
por: Yao, Shunhan, et al.
Publicado: (2022) -
Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma
por: Han, Cuifang, et al.
Publicado: (2023) -
A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes
por: Zhang, Qiyao, et al.
Publicado: (2020) -
Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)